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Introduction: 
Many different hepatic functions ar© deranged In viral 
hepatitis and albumin, which is synthesized In the liver, has 
been shown to undergo quantitative and qualitative changes in 
this disease state. Previous investigators have shown that there 
is a diminution of serum albumin levels in hepatitis.1  
and disturbances In the thymol turbidity and eephalin cholest¬ 
erol flocculation reactions in hepatitis are dependant primar¬ 
ily on the quantitative and qualitative changes In the serum 
20 globulins and albumin. 
Despite the availability of the radlolodlnated alb¬ 
umin technique Introduced by Sterlingwhich is a reliable 
and relatively simple method for studying albumin metabolism, 
no investigation of albumin metabolism in viral hepatitis has 
been undertaken. The only observation bearing on this problem 
was made by Sterling In his initial report where he presented 
data about one patient with hepatitis in whom the half-life of 
albumin was greatly shortened. 
Since viral hepatitis is, In most instances, a self 
limited disease, It presents an ideal opportunity to study the 
acute effects of the disease on albumin metabolism and then, 
using each patient as his own control subject, to restudy these 
patients after recovery. 
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This study was undertaken to Investigate albumin 
metabolism in acute viral hepatitis using the radioiodlnated 
albumin technique. 
. 
Materials and Methods: 
A. Clinical Material: 
All patients studied had been admitted to the West 
Haven Veterans Administration Hospital or the Grace-New Haven 
Community Hospital. Subjects for the study fell into three 
groups: 
1. Control Group: Control subjects consisted of normal 
medical students or patients with psychiatric disorders in 
normal physical health. They ranged In age from 23 to 49 years. 
None had albuminuria. The control subjects ate a normal diet and 
their weight was stable throughout the period of the study. 
2. Cirrhosis Group: Each of the patients had clinically 
evident Laennee*s Cirrhosis which was confirmed histologically. 
Each was In a stable phase of his disease. They ranged in age 
from 37 to 49 years and none had albuminuria. 
3. Hepatitis Group: The subjects with viral hepatitis, 
who ranged In age from 28 to 64 years, were studied as soon as 
possible after their admission to the hospital. They were in 
various stages of the acute phase of their Illness and had been 
admitted from 5 to 30 days following the onset of symptomatology. 
The degree of severity of the clinical disease varied consider- 
ably, and patients were classified as either severe, moderate, 
or mild hepatitis.* None had albuminuria. 
* - Clinical summaries will be found in the appendix. 
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A control subject was studied simultaneously with 
each subject with hepatitis in order to control the technical 
aspects of the investigation. When possible, a cirrhotic patient 
was also studied at the same time. 
Liver function tests were performed, on each patient 
with hepatitis at weekly intervals and in the other groups at 
least once before and once at the conclusion of the study. 
Liver function studies, which consisted of direct and total 
serum bilirubin* bromsulfalein retention, cephalin flocculation, 
thymol turbidity and serum alkaline phosphatase, were performed 
7 
according to methods previously described from this laboratory. 
Quantitative total protein and albumin determinations were made 
at the onset of the study and at weekly intervals thereafter to 
evaluate whether the subjects were in a steady state, i.e. alb¬ 
umin production was equal to albumin degradation. Filter paper 
electrophoresis was performed on 0.01 ml of serum using the 
Spinco hanging-strip method. The stripe were stained for pro¬ 
tein with bromphenol blue and quantitated with the Beckman An- 
alytrol.^ 
All the subjects were given 15 drops of Lugol's sol¬ 
ution on the day prior to and the day following the injection 
of the radioalbumln to minimize thyroid uptake of the 1-131- 
B. Methods: 
1. Preparation of radioalbumln for injection: The radio¬ 
albumin mixture used for injection was prepared by adding 4.0 ml 
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of 25% untagged human serum albumin (American Red Cross) to a 
sterile bottle containing 26.0 ml of physiologic saline, thus 
creating a concentration of approximately 28.5 mg albumin per ml. 
The radioactive iodinated albumin used was a commercial prepar¬ 
ation (AlbumotopeR» Squibb Laboratories) containing 50-65 mg 
protein per ml with benzyl alcohol as a preservative. Approxi¬ 
mately 300 microcuries of this preparation was introduced into 
the saline-albumin mixture after the removal of a sufficient 
amount of the solution so that the dosage bottle contained ex¬ 
actly 30.0 ml with 10 uc of radioactive iodinated albumin per ml. 
Each subject was given approximately 50 uc intravenously. The 
volume injected was measured for calculation of plasma volume. 
2, Collection and counting of samples: Blood specimens were 
collected in Vacutain@rR tubes containing ethylene diaminetetra- 
cetate (EDTA) (Sequestren©R) at 15 minutes, 24, 48 and 72 hours, 
and 5, 7» 10, 12, 14, and 17 days after injection of the radio- 
albumin. Some variation in ihe time of collection occurred in 
several subjects. The specimens were centrifuged and 1.0 ml 
aliquots of plasma were prepared in duplicate for counting in a 
well-type scintillation counter (Atomic Instrument Co. Well 
counter). Standards were prepared by diluting 0.10 ml of the 
dosage mixture to 500 ml of which 1,0 ml aliquots were counted. 
Three consecutive 24 hour urine collections were made beginning 
at the time of injection. After total urine volume was recorded, 
duplicate 3.0 ml aliquots were prepared. 
modification of Sterling’s technique which involved precipit¬ 
ation of albumin and counting the dry samples on planehettes 
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All blood and urine specimens for each subject were 
counted on the same day at the conclusion of the test period to 
eliminate the necessity of correcting for radioactive decay. All 
counts were finally expressed as counts/minute/ml. 
3. Calculations: From these values, the plasma volume was 
calculated by the use of Formula A: 
counts standard X dilution factor 
Formula A: Plasma VoXun© - ' counts’ of 15" minute sample.. 
which Is an application of the simple dilution principle. 
The radioactivity of the plasma samples (eounts/min- 
ute/ml) was plotted as the ordinate against time (days) on 
semilogarithmie graph paper. The resulting curve consisted of 
two components, a rapid initial fall followed by a more gradual, 
linear decline. (Figure I) The rapid .fall 'was interpreted as the 
period of Intravaseular-extravascular and intracellular-extra- 
cellular equilibrium,22 while the linear portion represented 
the actual decay of the 1-131 albumin. The extrapolation of the 
linear portion to zero time gave the value of albumin specific 
activity at the time of injection assuming complete distribu¬ 
tion. By halving this value and determining its intercept on 
the graph, the half-lire (T^) was determined. From this value 
the turnover rate was calculated, by the use of Formula B: 
Formula B: turnover rate =* = 0»u>93 
Tj T| 
which is derived from the equation for exponential decay: 
A A -fct A = Ap e 
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Figure I 

where: 
A = 1-131 tagged albumin at any time 
4©= I-131 tagged albumin at zero time 
t = time In days 
k = turnover rate as fraction, of the albumin 
turned over per day 
The exchangable albumin pool was determined by the method of 
30 Sterling' ; 
Formula G: Exchangable Albumin Pool = 
Alb, specific activity at zero time (ets/ml) _ eounts/mg albumin 
Quantitative albumin in plasma (mg%) 
then by isotope dilution principle: 
counts Injected. = grams albumin (E.A.P.) 
Albumin spec, activity (eounts/mg) 
The circulating albumin was similarly determined, using the 
albumin specific activity at zero time assuming mixing with 
circulating albumin only, l»e. counts of 15 minute sample, as 
the numerator in Formula G, 
The final results describing albumin turnover were 
expressed as functions of the exchangable pool, i.e. %/day; 
grams/day; grams/kg/day; and grams/l.73m2/day. 
The sample calculations for a normal control, H.O.G., 
are as follows: (See Figure I) 
Standard: 2,813?809 counts/ml (undiluted) 
15 minute sample: 4,531 counts/ml plasma 
Albumin specific activity at zero time: 1500 counts/ml 
Albumin half-life (T§): 10.0 days 
counts of standard X dilution factor 
Formula A: Plasma Volume = counts of 15 minute sample 
2.813.809 X 5 (ml ln.1ectej4 _ 
Plasma Volume = 4,531 eounts/ml ” 3104 ml 
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Formula B: Turnover rate = tJ = 
0.693 
Turnover rate = 10.0 =6.9 $/day 
Total Protein: 6.75 gms$ 
Albumin: 3*5 gms^ 
Formula C: E.A.P. 
Alb, spec, act, at zero time (counts/ml) 
Quantitative albumin (mg$) 
= counts/mg albumin, then: 
counts Injected = grams albumin (E.A.P.) 
Alb. spec. act. 
1500 counts/ml _ 
3*5 42.86 counts/ mg albumin 
2,813,809 X 5 = 
42.86 mg 327.9 grams = E.A.P. 
For circulating albumin: 
Formula D: counts of 15. minute,sarngle _ counts/mg albumin 
Quantitative albumin 
©l^^spec^act^ ” grams albumin (Circulating albumin) 
"1 g1^ s 129.45 count s/mg/albumin 
2*21.countaJL^mt s lo8#7 grams (circulating 
129.45 counts/mg albumin) 
U- i)'l 
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Results: 
The mean half-life of albumin turnover in 9 normal 
subjects was 11*6+ 1.4 days (Table I) with a mean turnover rate 
of 6.0+ o.7 /6/day. in the three patients with cirrhosis, the 
albumin turnover (T|) was 13.3+ 0.5 days with a turnover rate of 
5.2+ 0.4 %/daj (Table II). 
The mean albumin half-life in the 10 patients with 
hepatitis was 10.7+ 2.5 days. The mean turnover rate was 
6.8+ 1.6 %/day (Table III). However, in this group there were 
included two patients who were treated, with adrenocortical 
steroids during the course of their illness and their half-life 
was much shorter than the rest of the group, averaging 7*7 days 
with a turnover rate of 9.0 /6/day. Excluding these two patients, 
the remainder of the hepatitis group had a mean albumin half- 
life of 11.4+ 2.2 days and a mean turnover rate of 6.3+ 1*2 $/day. 
Three patients with hepatitis were restudied after 
their recovery. It was found that during their illness the mean 
albumin was 12.2+ 3*3 days and the mean turnover rate 5.7+ 1.3 
$/day; after recovery, the mean half-life of albumin was 13*1 + 
1.4 days, the mean turnover rate being 5.4+ 0.9 j6/day (Table IV). 
The mean value for th© exehangable albumin pool (EAP), 
based on the electrophoretic value of serum albumin, was 355 + 
64 grama in the normal subjects, 345 + 44 grams in the patients 
with cirrhosis and 326 + 79 grams in the patients with hepatitis 
(Table V). 
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Table V 
Group EAP Clrc. Alb 
Normal 
Control 
355 158 
Cirrhotics 345 181 
Hepatitis 326 136 
Sterling0 
Normal 
263 117 
.Ratio: mean cire. alb,/ EAP 
0.45 
0.52 
0.42 
0.45 
The actual turnover rate of albumin determined by 
multiplying the turnover rat© by the exehangable albumin pool 
was expressed as grams/day, grams/kg/day, and grams/l.73m2/day. 
Results are summarized in Table VI. 
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Discussion: 
A. Methods: 
The validity of the radloiodinated albumin technique 
for the study of albumin metabolism depends primarily on two 
assumptions: 
1* that all of the 1-131 la protein bound and 
remains 50 throughout the lifetime of the albumin, and 
2. that the 1-131 labeled albumin is not phys¬ 
iologically altered by the radioiodination procedure and. that 
it behaves in vivo like native protein. 
The commercial preparation used In this study (Album©- 
top@R, Squibb Laboratories) is manufactured by introducing iodine 
into the tyrosine moiety of the albumin molecule, incorporating 
a maximum of one atom of iodine per molecule at optimal pH and 
under conditions necessary to prevent protein denaturation.^ 
Unbound iodine is removed by an ion exchange method and comprises 
less than 2.0% of the total iodine content of the final prepara- 
tion, and usually is less than 1.0%.The integrity of the 
protein molecule and the stability of the radioactive label are 
tested by paper electrophoresis and bioaseay in d.ogs.2^ Dialysis 
of similar preparations by Bloom4 as well as precipitation tech¬ 
niques of comparable commercial products by the author' have 
shown that all of the radioactivity except for a negligible 
fraction is protein bound in the plasma. Furthermore, Sterling-*50 
17 
and McFarlane * have presented data to indicate that 1-131 re¬ 
mains bound to the albumin molecule throughout its lifetime. 
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Theoretic considerations which cast some doubt on this conclusion 
will be discussed below. Immunologic studies as well as observa¬ 
tions in other species have Indicated that tagged albumin closely 
resembles untreated, protein In physiologic behavior.The min¬ 
ute amount of albumin injected does not affect the metabolism to 
any appreciable degree* 
Differences In the rate of disappearance of radioalbumin 
labeled with C-14 and S-35 on the one hand and 1-131 on the other 
1 2 9 21 24 33 have been observed by several investigators. * 9 J - who 
noted that the albumin half-life of radiocarbon or radiosulfur- 
labeled albumin was almost twice that of the radllodinated com¬ 
pound, i.e. the turnover rate was half as rapid (Table VII). The 
conclusions were that iodlnated albumin may not be metabolized 
normally In man. Goldsworthy felt that these discrepancies may 
have been caused by alterations in the 1-131 labeled protein 
occurring during isolation, iodination and handling processes 
prior to its administration.5 Since most of these studies compare 
endogenously labeled albumin with C-14 or S-35 labeled amino 
acids with exogenously produced iodlnated albumin, it was post¬ 
ulated that perhaps the prolongation of the half-life with C-14 
or S-35 is caused by a reutilization of the radioactive elements 
following albumin degradation. Another possible explanation sug¬ 
gests that the chemically prepared radioiodlnated albumin was 
degraded abnormally rapidly. However, some investigators have 
observed that 85”95^ of C-14 is excreted within 10 days after 
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TABLE VII 
ALBUMIN HALF-LIVES FOR NORMAL SUBJECTS, 
1131, cl4, s35 and n15-LABELED ALBUMIN 
Radioisotope label Albumin half-life 
Investigator of albumin in days 
Armstrong (1) I131 9,7 
Dixon (8) x131 13,1 
Margen and Tarver (21) T131* 
1 S35* 
15.0 
24.0 
• 
I131 10,1 
Masouredis (24) I131 
c14** 
12.4 
33.5 
Volwiler (33) s35** 19.3 
London (16) N15** 20.1 
Kushner (14) I131 11.8 
Blahd (3) x131 12.9 
Sterling (30) I131 10.5 
Berson (2) ll31 17.0 
Kyropoulos I131 11.6 
* Simultaneous labeling of albumin molecule with S35 and x131 
** Biosynthetically labeled albumin 
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administration and thus discount the probability of reincorp¬ 
oration of the C-14 atom into the newly synthesized albumin 
2.4 
molecule. 
McFarlane has shown the iodination of the albumin mol - 
ecule with 6 or more atoms of 1-131 per molecule affects the pro¬ 
tein's physiologic activity by abnormally shortening its half- 
life. Albumin labeled with 0.5 atoms of iodine per molecule be¬ 
haved in a fashion similar to C-14 and 8-35 labeled protein and. 
presumably physiologically in vivog :l * although the preparation 
of the albumin itself differed in other ways as well. Other in¬ 
vestigators employing McFarlane*s technique for radlolodination 
and C-14 and 8-35 labeled albumin prepared, in donors found no 
appreciable difference in the disappearance rates in rabbits 
and rats.^,G' 
Margen and Tarver, using human serum albumin doubly 
labeled with methionine 8-35 and 1-131» showed that the half- 
life as determined by S-35 activity was 22.5 days and that de¬ 
termined by 1-131 was 10.5 days. These experiments led these 
authors to conclude: "... that 1-131 was lost in part from the 
albumin by a mechanism th^t did not involve the rupture of 
peptide bonds because this would liave resulted in ... the 
loss of the S-35 label.Volwiler and co-workers have independ- 
antly confirmed these findings.33 This discrepancy in half-lives, 
determined on the same albumin molecules by two different radio¬ 
active labels, is similar to the half-lives determined when 1-131 
or S-35 labeled albumin are adminstered seperateJLy. One may con¬ 
clude that deiodination in vivo in the absence of albumin degrad¬ 
ation is responsible for the apparent difference in albumin half- 
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life as determined by these different techniques. 
B. Results: 
The degradation curve of albumin is indicated as the 
semllogarithmic function of plasma radioalbumin activity plotted 
against time. It consists of two components, a rapid initial fall 
followed by a more gradual, linear decline. The rapid fall is 
interpreted to represent the period of intravascular-extravascular 
and Intra-eellular-extraf'ellular equilibration, while the linear 
o i 
portion represents the actual decay of the rad 1 o album in.' The 
validity of decay curves is based upon the assumption that a 
steady state exists with respect to albumin, that is that albumin 
production is equal t© albumin degradation. In patients with 
viral hepatitis, the existence of a steady state Is uncertain. 
One would expect, at least transiently, disturbances in the normal 
equilibrium of albumin metabolism. In the subjects in this study, 
who represent a group of patients with hepatitis of average sev¬ 
erity, there were no apparent deviations from the steady state. 
All of the patients were maintained on adequate diets in terms 
of proteins and calories and exhibited stable body weight and 
serum albumin levels (Table VIII). 
Several investigators has?noted a diminution of the 
concentration of serum albumin in viral hepatitis.31u Martin 
noted that there was a depression of the albumin component with 
a corresponding rise in gamma globulins as determined by serial 
electrophoretic examinations of the serum proteins. ^ There seemed 
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TABLE VIII 
EVALUATION OF THE STEADY STATE IN PATIENTS WITH 
INFECTIOUS HEPATITIS AS SHOWN BY SERUM ALBUMIN LEVELS 
AND BODY WEIGHT AT THE BEGINNING AND END OF THE STUDY 
Subiect 
Serum total 
bilirubin levels 
in mgm% 
Before After 
Albumin 
gins/100ml 
Before After 
Weight 
in lbs. 
Before After 
R. H. 3,5 1.3 4.3 4.3 156 158 
R. F. 2.0 1.5 3.6 4.1 132 129 
J. D. 24.0 3.5 3.7 3.6 138 126 
E. A. 3.0 1.7 2.2 2.5 154 153 
E. B. 11.9 1.7 3.2 3.3 196 196 
E. M. 8,9 7.2 2.6 2.4 143 142 
W.E.B. 20.1 3.3 3.2 3.4 172 166 
R. M. 1.2 0.3 3.5 3.6 150 151 
A» D. 33,2 29.3 3.0 2.9 162 156 
W. B. 21.S 4.2 2.7 2.8 237 228 
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to be a maximal depression within the first 10 days from the 
onset of the symtpoms which recovered, steadily thereafter. In 
addition, there was a disturbance of the alpha-2 and beta glob¬ 
ulins, notably between the 14th and, 30th days. 
In addition to these relatively large quantitative 
changes, qualitative changes in albumin have been postulated. In 
attempting to elucidate the mechanisms of the thymol turbidity 
and cephalin cholesterol flocculation reactions, M&glagan and 
Bunn noted that although normal albumin inhibited the floccu¬ 
lations caused by beta and gamma globulin components, the albumin 
on 
from some patients with hepatitis did not. They assumed that 
qualitative changes caused by the hepatitis were responsible. 
In view of the demonstration of both qualitative and 
quantitative alterations of serum albumin in hepatitis, it Is 
logical to assume that the metabolism may be altered as well. 
Would such disturbances in albumin metabolism be reflected in 
changes in the survival time and turnover rate of the serum alb¬ 
umin? This was implied by Sterling who reported a single case 
of hepatitis with markedly deranged albumin metabolism.His 
patient had a shortened albumin half-life of 7*4 days with a rapid 
turnover rate of 9*73 $/day. However, an unusually low exchangable 
albumin pool in this subject resulted in a near normal turnover 
rate, i.e. 14.1 grams/l.73a^/day, the normal mean being 15*4 + 
2.0 grams/l.73ni2/day. This is in contrast to patients with low 
serum albumin levels, such as in cirrhosis, who will usually have 
relatively long half-lives and, low albumin turnover rates, as was 
demonstrated by Sterling.-13 
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The albumin half-life and turnover rate of the hep¬ 
atitis patients in this study closely approximated those of the 
normal subjects. The three patients studied after recovery showed 
no significant change in their albumin turnover rates or* half- 
lives from the values observed during their acute illness. The 
patients with cirrhosis exhibited prolonged albumin half-lives 
and slower turnover rates. 
It was noted that the variation that occurred in the 
albumin half-life of the patients with hepatitis seemed to be 
systematically related to the severity of their illness. If one 
assumes that the serum bilirubin is an index of the severity of 
hepatic dysfunction, the d.ata indicate that an Inverse relation 
may exist between the maximal serum bilirubin level and the alb¬ 
umin half-life (Figure II). Further investigation is necessary 
to demonstrate such a correlation. 
Two patients with viral hepatitis (A.D. and W.B.) 
had shortened half-lives, Indeed, their turnover rates were 
almost twice those of the other hepatitis patients. Both of 
them, because of the severe clinical manifestations of their 
disease, received adrenocortical steroids therapeutically. Both 
had low exehangable albumin pools, although the absolute albumin 
turnover rate was still somewhat accelerated. The shorter half- 
life is compatible with the Increase in albumin turnover in¬ 
duced by steroids. Grossman et al. administered hydrocortisone 
and corticotropin to 10 normal subjects and demonstrated a 
marked Increase in albumin degradation.^0 Rothschild and co- 
workers found that albumin degradation increased by a mean of 
27$ in 5 male patients after the administration of adrenocortical 
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Figure II 
RELATIONSHIP OF ALBUMIN HALF-LIFE TO MAXIMAL 
SERUM BILIRUBIN LEVELS IN HEPATITIS 
S Adrenocortical steroid therapy 
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hormones.27 jt is Impossible to conclude whether the shortened 
half-life in my two patients is related to the severity of the 
hepatitis or the steroids. 
The normal mean for exehangable albumin pool as det¬ 
ermined in this study was 345 + 78 grams. This was higher than 
that obtained, by Sterling in his initial study~'J ( mean for 
normals: 232 + 48 grams), but more closely approximates the 
same author’s later work-^ (?14 + 48 grama). The ratio of circ¬ 
ulating albumin to the exehangable albumin pool, however, was 
the same (Table V), Margen, on the other hand, reports much 
21 
higher values for the exehangable albumin pools. Analysis of 
these data by Goldsworthy suggests that for various theoretic 
reasons Sterling’s figures are more probably correct* 
Other investigators employing the radioalbumin tech¬ 
nique have reported albumin half-lives for normal subjects 
within the range of values observed in this study (Table VII). 
2 One natable exception was Berson et al who noted a relatively 
longer half-life (17.0 days). These Investigators postulated 
that the distribution of the iodoalbumin does not occur com¬ 
pletely for 4 to 7 days after administration. Consequently, in¬ 
clusion of these pointin plotting the degradation curves was 
felt to contribute to erroneously faster turnover rates. In 
the present study, no appreciable difference in turnover rate 
could be detected by plotting the degradation curves on points 
following the 7th day as opposed to using the entire exponential. 
29 portion of the curve. Sterling and Steinfeld have pointed out 
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that Benson*3 ’’normal” data were obtained from patients with 
chronic disorders, but with normal serum albumin levels. Stein- 
feld has demonstrated that the half-life in such patients is 
several days longer than in truly normal subjects.2^ 
The various theoretic aspects of the radioiodinated 
albumin technique which are discussed above are of significance 
in terms of the absolute values of albumin metabolism. However, 
since there exists a direct relationship between the radioiodin¬ 
ated albumin and the biosynthetic isotope method, which is pre¬ 
sumably more reliable, the use of the former method is valid in 
studying relative variations in albumin metabolism in various 
diseases. 
It is surprising that the mean albumin turnover rate 
In paiieft'ts with viral hepatitis was not abnormal. It seems ob¬ 
vious that in the average mild case of the disease, albumin met¬ 
abolism does not differ substantially from the normal state. How¬ 
ever, in the most sever&y ill patients, in whom one would expect 
the greatest abberations in albumin turnover, the use of adreno¬ 
cortical steroids obscured the validity ©f the observations, 
and consequently such possible abnormalities. Further investig¬ 
ation of patients with severe hepatitis uncomplicated by adreno¬ 
cortical steroid therapy is needed. 
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Summary: 
Radiodinated albumin was used to study the albumin 
metabolism of 10 patients with viral hepatitis and in normal 
and cirrhotic control subjects. There was no significant ab¬ 
normality in albumin metabolism in the group of hepatitis patients, 
although the albumin half-life appeared to be related Inversely 
to the severity of the hepatitis. Three patients studied before 
and after recovery from the acute phase of their illness showed 
no significant change in albumin metabolism. Two patients treated 
with adrenocortical steroids had accelerated albumin turnover 
rates, which confirmed well established effects of such prepar¬ 
ations on albumin metabolism. The many factors which affect 
albumin metabolism in this and. similar studies as measured by 
various isotopic techniques were related to artifacts of synth¬ 
esis and variations in procedure. 
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Appendix: 
Clinical Summaries: 
A summary of the maximal values for liver function 
tests of the patients with hepatitis iS found in Table IX, 
R.H.; One month prior to admission, had gradual onset of nausea, 
malaise, fever, chills, dark urine, light stools and Icterus, 
Wife also icteric; physical examination revealed yellow scler- 
ae, tender liver palpable 2 fbs below costal margin; hospital 
course restricted to bed rest and supportive therapy, dis¬ 
charged 2 weeks after admission with normal liver function 
tests, (29 y.o. white, married male) 
R.F.; 33 y.o. white married male; two week history of malaise, 
fatigability, myalgia, headaches, chills, light stools, dark 
urine, jaundice; afebrile; physical examination revealed 
slight icterus, liver down 3 fbs, markedly tender, Teeated 
supportively with bed rest, discharged asymptomatic and with 
normal liver function tests three weeks after admission. 
J.D.; Tubercular and alcoholic patient, 52 y.o. white male, was 
being maintained on PZA when malaise, anorexia, dark urine 
and Jaundice appeared with an increase in B.S.P. retention 
and rise in SG-OT. There was marked hepatomegaly, 3-4 fbs 
below costal margin, and palmar erythema. Persistence of 
symptoms led to liver biopsy, which revealed severe hepa¬ 
titis with acute necrosis. Treatment was supportive, and 
patient’s liver function gradually returned to normal, how¬ 
ever, hospitalization continued because of pulmonary problem. 
E.A.; 37 y.o. white male with 1 week history of sore throat, 
fever, was given penicillin with subsequent swelling of 
hands, blistering and swelling of feet and legs, aching, 
and generalized pruritis. Liver was tender, enlarged 2 fbs 
below costal margin. Liver biopsy consistent with toxic 
hepatitis; hospital course restricted to supportive therapy, 
marked by gradual return to normal liver function. 
E.B.; 29 y.o. negro male with 8 day history of anorexia, vomit¬ 
ing, fatigue, myalgia, scleral icterus, dark urine, light 
stools; sister had hepatitis one month prior; physical ex¬ 
amination revealed scleral icterus, tender liver edge palp¬ 
able Just below costal margin; liver function tests grad¬ 
ually returned to normal on supportive therapy; discharged 
2 weeks after admission. 
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Table IX 
MAXIMAL VALUES FOR LIVER FUNCTION TESTS OF PATIENTS WITH HEPATITIS 
Patient Total 
Bill. 
B. S.P. 
$ ret. 
Transa¬ 
minase 
units 
Aik. Phos¬ 
phatase 
units 
Thymol 
Turbidity 
units 
Cephalln 
Flocculation 
R.H. 3.5 42.0$ 72 4.8 8.6 1 +/ 2 + 
R.F. 2.0 13.3$ 66 5.7 12.0 2+/5+ 
J.D. 24.0 64.0$ 830 10.3 6.8 2+/3+ 
E. A. 3.0 23-5# 91 20.0 1.6 o/o 
E.B. 11.9 75.0# 139 7.0 13.5 3+/4+ 
E.M. 3.9 63.9# 244 14.6 13.8 3+/4+ 
R.M. 1.2 49.5# 225 27.4 6.4 1+/2 + 
W. E. B. 20.1 54.4$ 750 9.3 13.4 3+A+ 
A. D. 38.8 - 4000 10.o 11.5 3+/4+ 
W.B. 21.8 74.0$ 125 5.0 15.0 0/0 
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E.M.; 29 y.o. negro male* had gradual onset on epigastric pain* 
with dark urine and scleral Icterus 6 days prior to admission; 
4 out of 6 members of family had recently had hepatitis; no 
hepatomegaly; liver biopsy revealed viral hepatitis; treated 
supportively, with rapid return to normal liver function. 
R.M.; 28 y.o. negro male; five days prior to admission had nausea, 
vomiting, dark urine; physical examination revealed minimal 
right upper quadrant tenderness, tender, round liver edge 2 
fbs below costal margin, no icterus. Hospital course support¬ 
ive; discharged three weeks after admission with normal liver 
function, 
A.D. 64 y.o. white male; two months prior to admission, had 
hemorrhagic episode from peptic ulcer requiring transfusion 
with 2 units blood; two weeks prior to admission, noted onset 
of anorexia, weakness, malaise, vomiting, dark urine, light 
stools, scleral icterus; had 15-20 lb, weight loss. Physical 
examination revealed marked icterus, bilateral palmar eryth¬ 
ema, suggestion of fullness of liver edge. Total bilirubin 
continued to rise, prednisone and. then ACTH therapy Instituted. 
Liver biopsy revealed severe viral hepatitis with subacute 
hepatic necrosis. Liver function tests began to gradually im¬ 
prove, then suddenly had severe, sharp efigastric pain with 
guarding and peritoneal rebound tenderness- perforated duod¬ 
enal ulcer - developed Ileus- treated with nasogastric 
suction, l.v. fluids, antibiotics, pressors - patient re¬ 
covered, but had another acute episode some days later, was 
unresponsive to therapy, and expired. 
W.EfB,; 35 y.o. white male had 1 week history of nausea and vomit¬ 
ing and one day prior to admission noted dark urine and 
scleral icterus. Physical examination revealed severe jaund¬ 
ice, but no organomegaly with only mild epigastric distress’ 
Liver biopsy revealed subsiding viral hepatitis; had asymptom¬ 
atic hospital course, received supportive therapy, discharged 
5 weeks after admission. 
W.B.: 35 y.o. negro male; noted myalgias and arthralgias 3 weeks 
prior to admission.Gradual appearance of icteric sclerae, 
pruritis, dark urine, gray stool; physical examination re¬ 
vealed scleral and palatine icterus, tender liver 3 fbs below 
costal margin. Serum bilirubin continued to climb, liver bi¬ 
opsy revealed severe Infectious hepatitis; clinical symptoms 
became more severe, patient begun on prednisone and then ACTH 
therapy with rapid alleviation of symptomatology and return 
to normal of hepatic function. Discharged asymptomatic 4 
weeks after admission. 
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